The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Open accessAbstract
BACKGROUND: Medulloblastoma is the most common malignant brain tumor in children. Despite recent improvements in cure rates, prediction of disease outcome remains a major challenge and survivors suffer from serious therapy-related side-effects. Recent data showed that patients with WNT-activated tumors have a favorable prognosis, suggesting that these patients could be treated less intensively, thereby reducing the side-effects. This illustrates the potential benefits of a robust classification of medulloblastoma patients and a detailed knowledge of associated biological mechanisms. METHODS AND FINDINGS: To get a better insight into the molecular biology of medulloblastoma we established mRNA expression profiles of 62 medulloblastomas and analyzed 52 of them also by comparative genomic hybridization (CGH) arrays. Five molecular subtypes were identified, characterized by WNT signaling (A; 9 cases), SHH signaling (B; 15 cases), expression of neuronal differentiation genes (C and D; 16 and 11 cases, respectively) or photoreceptor genes (D and E; both 11 cases). Mutations in beta-catenin were identified in all 9 type A tumors, but not in any other tumor. PTCH1 mutations were exclusively identified in type B tumors. CGH analysis identified several fully or partly subtype-specific chromosomal aberrations. Monosomy of chromosome 6 occurred only in type A tumors, loss of 9q mostly occurred in type B tumors, whereas chromosome 17 aberrations, most common in medulloblastoma, were strongly associated with type C or D tumors. Loss of the inactivated X-chromosome was highly specific for female cases of type C, D and E tumors. Gene expression levels faithfully reflected the chromosomal copy number changes. Clinicopathological features significantly different between the 5 subtypes included metastatic disease and age at diagnosis and histology. Metastatic disease at diagnosis was significantly associated with subtypes C and D and most strongly with subtype E. Patients below 3 yrs of age had type B, D, or E tumors. Type B included most desmoplastic cases. We validated and confirmed the molecular subtypes and their associated clinicopathological features with expression data from a second independent series of 46 medulloblastomas. CONCLUSIONS: The new medulloblastoma classification presented in this study will greatly enhance the understanding of this heterogeneous disease. It will enable a better selection and evaluation of patients in clinical trials, and it will support the development of new molecular targeted therapies. Ultimately, our results may lead to more individualized therapies with improved cure rates and a better quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
TM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837
Prediction of central nervous system embryonal tumour outcome based on gene expression
Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y. H., Goumnerova, L. C., Black, P. M., Lau, C., et al. (2002) · Nature · doi:10.1038/415436a · Cited by 2,371
Principles and Practice of Pediatric Oncology
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-636_3 · Cited by 2,027
— Tumors of the Central Nervous System
(2013) · Pediatric Radiotherapy Planning and Treatment · doi:10.1201/b14554-7 · Cited by 1,751
Gajjar, A., Chintagumpala, M., Ashley, D., Kellie, S., Kun, L. E., Merchant, T. E., Woo, S., Wheeler, G., Ahern, V., Krasin, M. J., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70867-1 · Cited by 951
Marino, S., Vooijs, M., van der Gulden, H., Jonkers, J., & Berns, A. (2000) · Genes & Development · doi:10.1101/gad.14.8.994 · Cited by 920
Mutations in SUFU predispose to medulloblastoma
Taylor, M. D., Liu, L., Raffel, C., Hui, C.-C., Mainprize, T. G., Zhang, X., Agatep, R., Chiappa, S., Gao, L., Lowrance, A., et al. (2002) · Nature Genetics · doi:10.1038/ng916 · Cited by 806
PAGE: Parametric Analysis of Gene Set Enrichment
Kim, S.-Y., & Volsky, D. J. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-144 · Cited by 779
Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone
Rutkowski, S., Bode, U., Deinlein, F., Ottensmeier, H., Warmuth-Metz, M., Soerensen, N., Graf, N., Emser, A., Pietsch, T., Wolff, J. E. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042176 · Cited by 751
Self-citationGenomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations
Thompson, M. C., Fuller, C., Hogg, T. L., Dalton, J., Finkelstein, D., Lau, C. C., Chintagumpala, M., Adesina, A., Ashley, D. M., Kellie, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4974 · Cited by 668
Sporadic medulloblastomas contain PTCH mutations.
Raffel, C., Jenkins, R. B., Frederick, L. A., Hebrink, D. M., Alderete, B. E., Fults, D. W., & James, C. D. (1997) · PubMed · Cited by 570
MacDonald, T. J., Brown, K. M., LaFleur, B., Peterson, K., Lawlor, C., Chen, Y., Packer, R. J., Cogen, P., & Stephan, D. A. (2001) · Nature Genetics · doi:10.1038/ng731 · Cited by 455
Ellison, D. W., Onilude, O. E., Lindsey, J. C., Lusher, M. E., Weston, C. L., Taylor, R. E., Pearson, A. D., & Clifford, S. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5479 · Cited by 435
Self-citationSporadic medulloblastomas contain oncogenic beta-catenin mutations.
Zurawel, R. H., CHIAPPA, S. A., Allen, C., & Raffel, C. (1998) · PubMed · Cited by 387
Pietsch, T., Waha, A., Koch, A., Kraus, J., Albrecht, S., Tonn, J. C., Sörensen, N., Berthold, F., Henk, B., Schmandt, N., et al. (1997) · PubMed · Cited by 373
Self-citationHistopathologic grading of medulloblastomas: A Pediatric Oncology Group Study
Eberhart, C. G., Kepner, J. L., Goldthwaite, P. T., Kun, L. E., Duffner, P. K., Friedman, H. S., Strother, D. R., & Burger, P. C. (2002) · Cancer · doi:10.1002/cncr.10189 · Cited by 316
Wolter, M., REIFENBERGER, J., Sommer, C., Ruzicka, T., & Reifenberger, G. (1997) · PubMed · Cited by 297
APC Mutations in Sporadic Medulloblastomas
Huang, H., Mahler-Araujo, B. M., Sankila, A., Chimelli, L., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64747-5 · Cited by 280
Human and mouse oligonucleotide-based array CGH
van den IJssel, P. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni191 · Cited by 274
Clifford, S. C., Lusher, M. E., Lindsey, J. C., Langdon, J. A., Gilbertson, R. J., Straughton, D., & Ellison, D. W. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3446 · Cited by 270
Self-citationCGHcall: calling aberrations for array CGH tumor profiles
van de Wiel, M. A., Kim, K. I., Vosse, S. J., van Wieringen, W. N., Wilting, S. M., & Ylstra, B. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm030 · Cited by 240
Self-citationDeletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
Dahmen, R. P., Koch, A., Denkhaus, D., Tonn, J.-C., Sörensen, N., Berthold, F., Behrens, J., Birchmeier, W., Wiestler, O. D., & Pietsch, T. (2001) · PubMed · Cited by 216
Self-citationNuclear Localization and Mutation of β-Catenin in Medulloblastomas
Eberhart, C. G., Tihan, T., & Burger, P. C. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.4.333 · Cited by 215
Combined Histopathological and Molecular Cytogenetic Stratification of Medulloblastoma Patients
Lamont, J. M., McManamy, C. S., Pearson, A. D., Clifford, S. C., & Ellison, D. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0721 · Cited by 209
Self-citationMedulloblastoma with extensive nodularity: a variant with favorable prognosis
Giangaspero, F., Perilongo, G., Fondelli, M. P., Brisigotti, M., Carollo, C., Burnelli, R., Burger, P. C., & Garrè, M. L. (1999) · Journal of Neurosurgery · doi:10.3171/jns.1999.91.6.0971 · Cited by 205
Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins
Felsani, A., Mileo, A. M., & Paggi, M. G. (2006) · Oncogene · doi:10.1038/sj.onc.1209621 · Cited by 182
Central and Extrapontine Myelinolysis: Then…and Now
Kleinschmidt-DeMasters, B. K., Rojiani, A. M., & Filley, C. M. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000196131.72302.68 · Cited by 169
Clinical and molecular stratification of disease risk in medulloblastoma
Gilbertson, R., Wickramasinghe, C., Hernan, R., Balaji, V, Hunt, D., Jones-Wallace, D., Crolla, J., Perry, R., Lunec, J., Pearson, A., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1987 · Cited by 168
Self-citationGrotzer, M. A., Hogarty, M. D., Janss, A. J., Liu, X., Zhao, H., Eggert, A., Sutton, L. N., RORKE, L. B., Brodeur, G. M., & Phillips∥, P. C. (2001) · PubMed · Cited by 168
C-MYC expression in medulloblastoma and its prognostic value
Herms, J., Neidt, I., Lüscher, B., Sommer, A., Schürmann, P., Schröder, T., Bergmann, M., Wilken, B., Probst-Cousin, S., Hernáiz-Driever, P., et al. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000920)89:5<395::aid-ijc1>3.0.co;2-v · Cited by 164
Self-citationDi, C., Liao, S., Adamson, D. C., Parrett, T. J., Broderick, D. K., Shi, Q., Lengauer, C., Cummins, J. M., Velculescu, V. E., Fults, D. W., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.919.65.3 · Cited by 160
Somatic mutations ofWNT/wingless signaling pathway components in primitive neuroectodermal tumors
Koch, A., Waha, A., Tonn, J. C., S�rensen, N., Berthold, F., Wolter, M., Reifenberger, J., Hartmann, W., Friedl, W., Reifenberger, G., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1342 · Cited by 160
Self-citationMcManamy, C. S., Pears, J., Weston, C. L., Hanzely, Z., Ironside, J. W., Taylor, R. E., Grundy, R. G., Clifford, S. C., & Ellison, D. W. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00058.x · Cited by 144
Self-citationBayani, J., Zieleńska, M., Marrano, P. M., Ng, Y. K., Taylor, M. D., Jay, V., Rutka, J. T., & Squire, J. A. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.93.3.0437 · Cited by 137
PDGFRB is overexpressed in metastatic medulloblastoma
Gilbertson, R. J., & Clifford, S. C. (2003) · Nature Genetics · doi:10.1038/ng1103-197 · Cited by 112
Self-citationRole of Wnt pathway in medulloblastoma oncogenesis
Yokota, N., Nishizawa, S., Ohta, S., Date, H., Sugimura, H., Namba, H., & Maekawa, M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10559 · Cited by 111
Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma
Gilbertson, R. J., Pearson, A., Perry, R. H., et al. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.96 · Cited by 109
OTX1 and OTX2 Expression Correlates With the Clinicopathologic Classification of Medulloblastomas
de Haas, T. G., Oussoren, E., Grajkowska, W., Perek‐Polnik, M., Popović, M., Zaletel, L. Z., Perera, M., Corte, G., Wirths, O., Sluis, P. V., et al. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000199576.70923.8a · Cited by 101
Self-citationGenomic Amplification of Orthodenticle Homologue 2 in Medulloblastomas
Boon, K., Eberhart, C. G., & Riggins, G. J. (2005) · Cancer Research · doi:10.1158/0008-5472.703.65.3 · Cited by 100
Badiali, M., Pession, A., Basso, G., Andreini, L., Rigobello, L., Galassi, E., & Giangaspero, F. (1991) · Tumori Journal · doi:10.1177/030089169107700205 · Cited by 96
Isochromosome 17q Is a Negative Prognostic Factor in Poor-Risk Childhood Medulloblastoma Patients
Pan, E., Pellarin, M., Holmes, E., Smirnov, I. V., Misra, A., Eberhart, C. G., Burger, P. C., Biegel, J. A., & Feuerstein, B. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0465 · Cited by 89
Boon, K., Edwards, J. B., Siu, I., Olschner, D., Eberhart, C. G., Marra, M. A., Strausberg, R. L., & Riggins, G. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207043 · Cited by 78
Marcus, D. M., Brooks, S. E., Leff, G., Mccormick, R., Thompson, T., Anfinson, S., Lasudry, J., & Albert, D. M. (1998) · Survey of Ophthalmology · doi:10.1016/s0039-6257(98)00019-8 · Cited by 72
Perentes, E., Rubinstein, L. J., Herman, M. M., et al. (1986) · Acta Neuropathologica · doi:10.1007/bf00688043 · Cited by 71
Array CGH analysis of pediatric medulloblastomas
Rossi, M. R., Conroy, J. M., McQuaid, D., Nowak, N. J., Rutka, J. T., & Cowell, J. K. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20292 · Cited by 70
Molecular pathogenesis of childhood brain tumors
Pietsch, T., Taylor, M. D., & Rutka, J. T. (2004) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-2750-7 · Cited by 64
Self-citationMutational analysis of PDGFR–RAS/MAPK pathway activation in childhood medulloblastoma
Gilbertson, R. J., Langdon, J. A., Hollander, A. B., Hernán, R., Hogg, T. L., Gajjar, A. J., Fuller, C. E., & Clifford, S. C. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.023 · Cited by 49
Self-citationTransgenic E2F1 Expression in the Mouse Brain Induces a Human-Like Bimodal Pattern of Tumors
Olson, M. V., Johnson, D. G., Jiang, H., Xu, J., Alonso, M. M., Aldape, K., Fuller, G. N., Bekele, B. N., Yung, W. K. A., Gomez‐Manzano, C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2973 · Cited by 34
Korf, H., Korl, B., Schachenmayr, W., Chader, G. J., & Wiggert, B. O. (1992) · Acta Neuropathologica · doi:10.1007/bf00310024 · Cited by 26
Tumors of the Central Nervous System
Tamburro, R. F., Barfield, R. C., & Gajjar, A. J. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6356-5_34 · Cited by 19
Iolascon, A., Lania, A., Badiali, M., Pession, A., Saglio, G. N., Giangaspero, F., del Giudice, E. M., Perrotta, S., & Cutillo, S. (1991) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950190406 · Cited by 14
Kramm, C. M., Korf, H., Czerwionka, M., Schachenmayr, W., & Grip, W. J. D. (1991) · Acta Neuropathologica · doi:10.1007/bf00305871 · Cited by 14
Cited by
Molecular subgroups of medulloblastoma: the current consensus
Taylor, M. D., Northcott, P. A., Korshunov, A., Remke, M., Cho, Y.-J., Clifford, S. C., Eberhart, C. G., Parsons, D. W., Rutkowski, S., Gajjar, A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0922-z · Cited by 1,936
Self-citationKillela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368
Medulloblastoma Comprises Four Distinct Molecular Variants
Northcott, P. A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C. G., Mack, S., Bouffet, E., Clifford, S. C., Hawkins, C. E., French, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4324 · Cited by 1,339
Self-citationThe whole-genome landscape of medulloblastoma subtypes
Northcott, P. A., Buchhalter, I., Morrissy, A. S., Hovestadt, V., Weischenfeldt, J., Ehrenberger, T., Gröbner, S., Segura-Wang, M., Zichner, T., Rudneva, V. A., et al. (2017) · Nature · doi:10.1038/nature22973 · Cited by 1,112
Self-citationKool, M., Korshunov, A., Remke, M., Jones, D. T. W., Schlanstein, M., Northcott, P. A., Cho, Y.-J., Koster, J., Schouten-van Meeteren, A., van Vuurden, D., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0958-8 · Cited by 1,056
Self-citation
Metadata
- Authors
- Kool, M., Koster, J., Bunt, J., Hasselt, N. E., Lakeman, A., van Sluis, P., Troost, D., Meeteren, N. S.-V., Caron, H. N., Cloos, J., Mršić, A., Ylstra, B., Grajkowska, W., Hartmann, W., Pietsch, T., Ellison, D., Clifford, S. C., & Versteeg, R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-08-28
- Volume
- 3
- Issue
- 8
- Pages
- e3088
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2140266186
- Cited by
- 722
- References
- 53
- FWCI
- 18.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.